Streamline Health Solutions (STRM) Misses Q2 EPS by 2c

Streamline Health Solutions (NASDAQ: STRM) reported Q2 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $4.5 million versus the consensus estimate of $4.97 million.

For earnings history and earnings-related data on Streamline Health Solutions (STRM) click here.

You May Also Be Interested In

• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
• Taysha Gene Therapies (TSHA) PT Raised to $11 at Citizens on REVEAL Data Update
• AMN Healthcare (AMN) Reiterated at Market Outperform by Citizens